Lisanne Schenkeveld

Learn More
The current guidelines have recommended postponing noncardiac surgery (NCS) for > or =6 weeks after bare metal stent (BMS) placement and for > or =1 year after drug-eluting stent (DES) placement. However, much debate has ensued about these intervals. The aim of the present study was to assess the influence of different intervals between stenting and NCS and(More)
OBJECTIVE To assess whether the obesity paradox persists in the long term and to study the effect of optimal medical treatment on this phenomenon. DESIGN A retrospective cohort study. SETTING A tertiary care centre in Rotterdam. PARTICIPANTS From January 2000 to December 2005, 6332 patients undergoing percutaneous coronary intervention for coronary(More)
BACKGROUND The use of drug eluting stents (DES) in patients with a successfully recanalized chronic total occlusion (CTO) has been associated with a significant decrease in the need for repeat revascularization, and a favorable short-term clinical outcome when compared with the use of bare metal stents (BMS). Our group, however, has previously reported(More)
OBJECTIVES The purpose of this study was to investigate the impact of everolimus-eluting stents (EES) in comparison with bare-metal stents (BMS), sirolimus-eluting stents (SES), and paclitaxel-eluting stents (PES) on the 6-month clinical outcomes in an all-comer population. BACKGROUND EES have been shown to be effective in the context of randomized trials(More)
AIM Reperfusion therapy in acute myocardial infarction reduces infarct size and increases hospital survival. We investigated whether the benefit of reperfusion therapy for myocardial infarction was sustained long-term and assessed the gain in life expectancy by reperfusion therapy. METHODS AND RESULTS We analysed the outcome of 533 patients (mean age 56(More)
BACKGROUND Health status has become increasingly important as an outcome measure in patients with cardiovascular disease. Poor patient-rated health status has been shown to predict mortality in patients with coronary artery disease and heart failure. In patients treated with percutaneous coronary intervention (PCI), we examined whether poor health status(More)
  • 1